IP Verse

Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) Populations - EP3400947

The patent EP3400947 was granted to Ionis Pharmaceuticals on Aug 23, 2023. The application was originally filed on Feb 14, 2014 under application number EP18179911A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3400947

IONIS PHARMACEUTICALS
Application Number
EP18179911A
Filing Date
Feb 14, 2014
Status
Granted And Under Opposition
Jul 21, 2023
Grant Date
Aug 23, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AMMELBURGMay 22, 2024FISH & RICHARDSON PCADMISSIBLE

Patent Citations (90) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20020399998-
DESCRIPTIONUS20020419532-
DESCRIPTIONUS20070989574-
DESCRIPTIONUS20080026995-
DESCRIPTIONUS20080026998-
DESCRIPTIONUS20080056564-
DESCRIPTIONUS20080086231-
DESCRIPTIONUS20080097787-
DESCRIPTIONUS20080099844-
DESCRIPTIONUS20100915408-
DESCRIPTIONWO1998DK00393-
DESCRIPTIONWO2003US33466-
DESCRIPTIONWO2005US19219-
DESCRIPTIONWO2008US64591-
DESCRIPTIONWO2008US66154-
DESCRIPTIONWO2008US68922-
DESCRIPTIONUS13037799P
DESCRIPTIONUS2004171570
DESCRIPTIONUS2004208856
DESCRIPTIONUS2005130923
DESCRIPTIONUS2006264395
DESCRIPTIONUS2007287831
DESCRIPTIONUS2008039618
DESCRIPTIONUS4981957
DESCRIPTIONUS5034506
DESCRIPTIONUS5118800
DESCRIPTIONUS5166315
DESCRIPTIONUS5185444
DESCRIPTIONUS5319080
DESCRIPTIONUS5359044
DESCRIPTIONUS5393878
DESCRIPTIONUS5446137
DESCRIPTIONUS5466786
DESCRIPTIONUS5514785
DESCRIPTIONUS5519134
DESCRIPTIONUS5567811
DESCRIPTIONUS5576427
DESCRIPTIONUS5591722
DESCRIPTIONUS5597909
DESCRIPTIONUS5610300
DESCRIPTIONUS5627053
DESCRIPTIONUS5639873
DESCRIPTIONUS5646265
DESCRIPTIONUS5670633
DESCRIPTIONUS5698685
DESCRIPTIONUS5700920
DESCRIPTIONUS5792847
DESCRIPTIONUS6268490
DESCRIPTIONUS6525191
DESCRIPTIONUS6600032
DESCRIPTIONUS6670461
DESCRIPTIONUS6673661
DESCRIPTIONUS6770748
DESCRIPTIONUS6794499
DESCRIPTIONUS7034133
DESCRIPTIONUS7053207
DESCRIPTIONUS7399845
DESCRIPTIONUS7427672
DESCRIPTIONUS7598227
DESCRIPTIONUS7750141
DESCRIPTIONWO0063364
DESCRIPTIONWO0149687
DESCRIPTIONWO03004602
DESCRIPTIONWO2004093783
DESCRIPTIONWO2004106356
DESCRIPTIONWO2005021570
DESCRIPTIONWO2005121371
DESCRIPTIONWO2006047842
DESCRIPTIONWO2007134181
DESCRIPTIONWO2008101157
DESCRIPTIONWO2008150729
DESCRIPTIONWO2008154401
DESCRIPTIONWO2009006478
DESCRIPTIONWO2010036696
DESCRIPTIONWO2011139702
DESCRIPTIONWO2012149495
DESCRIPTIONWO9414226
DESCRIPTIONWO9839352
DESCRIPTIONWO9914226
OPPOSITIONUS2011060030
OPPOSITIONWO2004093783
OPPOSITIONWO2010080953
OPPOSITIONWO2010083615
OPPOSITIONWO2011123401
OPPOSITIONWO2012149495
OPPOSITIONWO2012177947
OPPOSITIONWO2014179626
SEARCHWO2011123401
SEARCHWO2012149495
SEARCHWO2014179626

Non-Patent Literature (NPL) Citations (117) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALBAEK et al., J. Org. Chem., (20060000), vol. 71, pages 7731 - 7740-
DESCRIPTION- ALLSHIRE, Science, (20020000), vol. 297, pages 1818 - 1819-
DESCRIPTION- ALTMANN et al., Biochem. Soc. Trans., (19960000), vol. 24, pages 630 - 637-
DESCRIPTION- ALTMANN et al., Chimia, (19960000), vol. 50, pages 168 - 176-
DESCRIPTION- ALTMANN et al., Nucleosides Nucleotides, (19970000), vol. 16, pages 917 - 926-
DESCRIPTION- ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, page 403 410-
DESCRIPTION- Antisense Research and Applications, CRC Press, (19930000), pages 276 - 278-
DESCRIPTION- Arch. Int. Med., (19880000), vol. 148, pages 36 - 39-
DESCRIPTION- BAKER et al., J. Biol. Chem., (19970000), vol. 272, pages 11944 - 12000-
DESCRIPTION- BRAASCH et al., Biochemistry, (20020000), vol. 41, pages 4503 - 4510-
DESCRIPTION- BRAASCH et al., Chem. Biol., (20010000), vol. 8, pages 1 - 7-
DESCRIPTION- BRISSON et al., Pharmacogenet Genom, (20100000), vol. 20, pages 742 - 747-
DESCRIPTION- CATAPANO et al., Atherosclerosis, (20110000), vol. 217S, pages S1 - S44-
DESCRIPTION- CHAN et al., Clin. Chem, (20020000), pages 278 - 283-
DESCRIPTION- CHAN et al., Int J Clin Pract, (20080000), vol. 62, pages 799 - 809-
DESCRIPTION- CHATTOPADHYAYA et al., J. Org. Chern., (20090000), vol. 74, pages 118 - 134-
DESCRIPTION- Circulation, (20020000), vol. 106, pages 3143 - 421-
DESCRIPTION- DAVIDSSON et al., J. Lipid Res., (20050000), vol. 46, pages 1999 - 2006-
DESCRIPTION- Diabetes Care, ADA, (20080000), vol. 31, pages S12 - S54-
DESCRIPTION- ELAYADI et al., Curr. Opinion Invens. Drugs, (20010000), vol. 2, pages 558 - 561-
DESCRIPTION- FERN et al., J Clin Pathol, (20080000), vol. 61, pages 1174 - 118-
DESCRIPTION- FREDRICKSON et al., New Eng J Med, (19670000), vol. 276, no. 1, pages 34 - 42-
DESCRIPTION- FREDRICKSON; LEE, Circulation, (19650000), vol. 31, pages 321 - 327-
DESCRIPTION- FRIEDEN et al., Nucleic Acids Research, (20030000), vol. 21, pages 6365 - 6372-
DESCRIPTION- FRIER et al., Nucleic Acids Research, (19970000), vol. 25, no. 22, pages 4429 - 4443-
DESCRIPTION- GASTALDELLI et al., J Appl. Physiol, (19990000), vol. 87, pages 1813 - 1822-
DESCRIPTION- GAUDET et al., Atherosclerosis Supplements, (20100000), vol. 11, pages 55 - 60-
DESCRIPTION- GAUTSCHI et al., J. Natl. Cancer Inst., (20010300), vol. 93, pages 463 - 471-
DESCRIPTION- "GENBANK", Database accession no. NM 000040.1-
DESCRIPTION- "GENBANK", Database accession no. NT -033899.8-
DESCRIPTION- "GENBANK", Database accession no. NT 033899.8-
DESCRIPTION- "GenBank", Database accession no. NT -035088.1-
DESCRIPTION- "GenBank", Database accession no. NT 035088.1-
DESCRIPTION- GeneReviewsTM [Internet, University of Washington, Seattle, (19991012), pages 1993 - 2013-
DESCRIPTION- GORDON et al., Am. J. Med., (19770000), vol. 62, pages 707 - 714-
DESCRIPTION- "GPIHBP1, APOA5, LMF1 or other genes leading to dysfunctional LPL. Brunzell", GeneReviewsTM [Internet, University of Washington, (19991012), pages 1993 - 2013-
DESCRIPTION- GU et al., Nucleosides, Nucleotides & Nucleic Acids, (20050000), vol. 24, no. 5-7, pages 993 - 998-
DESCRIPTION- GU et al., Oligonucleotides, (20030000), vol. 13, no. 6, pages 479 - 489-
DESCRIPTION- GU et al., Tetrahedron, (20040000), vol. 60, no. 9, pages 2111 - 2123-
DESCRIPTION- HALL; 2002 et al., Science, vol. 297, pages 2232 - 2237-
DESCRIPTION- HEGELE et al., Hum Mol Genet, (20090000), vol. 18, pages 4189 - 4194-
DESCRIPTION- HEGELE; POLLEX, Mol Cell Biochem, (20090000), vol. 326, pages 35 - 43-
DESCRIPTION- HERTZ et al., JBiol Chern, (19950000), vol. 270, no. 22, pages 13470 - 13475-
DESCRIPTION- HORVATH et al., Tetrahedron Letters, (20070000), vol. 48, pages 3621 - 3623-
DESCRIPTION- JAMA, (20010000), vol. 285, pages 2486 - 2497-
DESCRIPTION- JENUWEIN, Science, (20020000), vol. 297, pages 2215 - 2218-
DESCRIPTION- JONES, L.J. et al., Analytical Biochemistry, (19980000), vol. 265, pages 368 - 374-
DESCRIPTION- KASHYAP, Am. J. Cardiol., (19980000), vol. 82, pages 42U - 48U-
DESCRIPTION- KOSHKIN et al., Tetrahedron, (19980000), vol. 54, pages 3607 - 3630-
DESCRIPTION- KUMAR et al., Bioorg. Med. Chem. Lett., (19980000), vol. 8, pages 2219 - 2222-
DESCRIPTION- KUMAR et al., Bioorg. Med. Chern. Lett., (19980000), vol. 8, pages 2219 - 2222-
DESCRIPTION- LEE et al., Arterioscler Thromb Vasc Biol, (20030000), vol. 23, pages 853 - 858-
DESCRIPTION- LEUMANN, Bioorg. Med. Chem., (20020000), vol. 10, pages 841 - 854-
DESCRIPTION- LEUMANN; CHRISTIAN J, Bioorg. & Med. Chem., (20020000), vol. 10, pages 841 - 854-
DESCRIPTION- MAHER; DOLNICK, Nuc. Acid. Res., (19880000), vol. 16, pages 3341 - 3358-
DESCRIPTION- MARTIN, Helv. Chim. Acta, (19950000), vol. 78, pages 486 - 504-
DESCRIPTION- MAUGER et al., J. Lipid Res, (20060000), vol. 47, pages 1212 - 1218-
DESCRIPTION- MENDIVIL et al., Circulation, (20110000), vol. 124, pages 2065 - 2072-
DESCRIPTION- MITTENDORFER et al., Diabetes, (20030000), vol. 52, pages 1641 - 1648-
DESCRIPTION- NAUWELAERTS et al., J. Am. Chem. Soc., (20070000), vol. 129, no. 30, pages 9340 - 9348-
DESCRIPTION- NAUWELAERTS et al., Nucleic Acids Research, (20050000), vol. 33, no. 8, pages 2452 - 2463-
DESCRIPTION- NORDESTGAARD et al., Arteriosclerosis, (19880000), vol. 8, pages 421 - 428-
DESCRIPTION- NORDESTGAARD et al., J Lipid Res, (19880000), vol. 29, pages 1491 - 1500-
DESCRIPTION- NORMAND-LAUZIERE et al., PLoS. One, (20100000), vol. 5, page e10956-
DESCRIPTION- ONAT, Atherosclerosis, (20030000), vol. 168, pages 81 - 89-
DESCRIPTION- OOI et al., Clinical Sci, (20080000), vol. 114, pages 611 - 624-
DESCRIPTION- OOI et al., Clin. Sci, (20080000), vol. 114, pages 611 - 624-
DESCRIPTION- ORUM et al., Curr. Opinion Mol. Ther., (20010000), vol. 3, pages 239 - 243-
DESCRIPTION- PAL-BHADRA et al., Science, (20040000), vol. 303, pages 669 - 672-
DESCRIPTION- ROBEYNS et al., Acta Crystallographica, Section F: Structural Biology and Crystallization Communications, (20050000), vol. F61, no. 6, pages 585 - 586-
DESCRIPTION- ROBEYNS et al., J. Am. Chem. Soc., (20080000), vol. 130, no. 6, pages 1979 - 1984-
DESCRIPTION- SACKS et al., Circulation, (20000000), vol. 102, pages 1886 - 1892-
DESCRIPTION- SHACHTER, Curr. Opin. Lipidol, (20010000), vol. 12, pages 297 - 304-
DESCRIPTION- SINGH et al., Chem. Commun., (19980000), vol. 4, pages 455 - 456-
DESCRIPTION- SINGH et al., J. Org. Chem., (19980000), vol. 63, pages 10035 - 10039-
DESCRIPTION- SINGH et al., J. Org. Chern., (19980000), vol. 63, pages 10035 - 10039-
DESCRIPTION- SMITH; WATERMAN, Adv. Appl. Math., (19810000), vol. 2, pages 482 - 489-
DESCRIPTION- SRIVASTAVA et al., J. Am. Chem. Soc., (20070000), vol. 129, no. 26, pages 8362 - 8379-
DESCRIPTION- SRIVASTAVA et al., J. Am. Chern. Soc., (20070000), vol. 129, no. 26, pages 8362 - 8379-
DESCRIPTION- TOSKES, Gastroenterol Clin North Am, (19900000), vol. 19, pages 783 - 791-
DESCRIPTION- TREMBLAY et al., J Clin Lipidol, (20110000), vol. 5, pages 37 - 44-
DESCRIPTION- VERBEURE et al., Nucleic Acids Research, (20010000), vol. 29, no. 24, pages 4941 - 4947-
DESCRIPTION- VERDEL et al., Science, (20040000), vol. 303, pages 672 - 676-
DESCRIPTION- VOLPE et al., Science, (20020000), vol. 297, pages 1833 - 1837-
DESCRIPTION- WAHLBERG et al., Acta Med Scand, (19880000), vol. 224, pages 319 - 327-
DESCRIPTION- WAHLESTEDT et al., Proc. Natl. Acad. Sci. U. S. A., (20000000), vol. 97, pages 5633 - 5638-
DESCRIPTION- WANG et al., J. Am. Chem., (20000000), vol. 122, pages 8595 - 8602-
DESCRIPTION- WANG et al., J. Org. Chem., (20010000), vol. 66, pages 8478 - 82-
DESCRIPTION- WANG et al., J. Org. Chem., (20030000), vol. 68, pages 4499 - 4505-
DESCRIPTION- WANG et al., Nucleosides, Nucleotides & Nucleic Acids, (20010000), vol. 20, no. 4-7, pages 785 - 788-
DESCRIPTION- WATTS et al., Diabetes, (20030000), vol. 52, pages 803 - 811-
DESCRIPTION- WEISSGLAS-VOLKOV; PAJUKANTA, J Lipid Res, (20100000), vol. 51, pages 2032 - 2057-
DESCRIPTION- WOOLF et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 7305 - 7309-
DESCRIPTION- YUAN et al., CMAJ, (20070000), vol. 176, pages 1113 - 1120-
DESCRIPTION- ZHANG; MADDEN, Genome Res., (19970000), vol. 7, page 649 656-
OPPOSITION- Anonymous, "Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome", Arrowhead Pharmaceuticals, (20240902), Arrowhead Pharmaceuticals, URL: https://ir.arrowheadpharma.com/node/19286/pdf, XP093212562-
OPPOSITION- Anonymous, "Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in Hypertriglyceridemia", Clinical Trials, (20220127), pages 1 - 10, XP093190618-
OPPOSITION- Anonymous, "Waylivra (volanesorsen)", European Medicines Agency, (20190401), pages 1 - 3, XP093190622-
OPPOSITION- Kinnunen Paavo K.J., Ehnholm Christian, "Effect of serum and C‐apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase", FEBS Letters, NL , (19760615), vol. 65, no. 3, doi:10.1016/0014-5793(76)80145-7, ISSN 0014-5793, pages 354 - 357, XP093190559
OPPOSITION- Jennifer B. Christian; Nancy Bourgeois; Rose Snipes; Kimberly A. Lowe;, "Prevalence of Severe (500 to 2,000 mg/dl) Hypertriglyceridemia in United States Adults", AMERICAN JOURNAL OF CARDIOLOGY., CAHNERS PUBLISHING CO., NEWTON, MA,, US, US , vol. 107, no. 6, doi:10.1016/j.amjcard.2010.11.008, ISSN 0002-9149, pages 891 - 897, XP028168440
OPPOSITION- Sehayek Ephraim, Eisenberg Shlomo, "Mechanisms of Inhibition by Apolipoprotein C of Apolipoprotein Edependent Cellular Metabolism of Human Triglyceride-rich Lipoproteins through the Low Density Lipoprotein Receptor Pathway", The Journal of Biological Chemistry, (19910925), vol. 266, no. 27, doi:10.1016/S0021-9258(18)55263-7, pages 18259 - 18267, XP093190585
OPPOSITION- Huynh Karina, "Targeting apoc-III to lower triglycerides", Nature Reviews Cardiology, Nature Publishing Group, GB, GB , (20150201), vol. 12, no. 2, doi:10.1038/nrcardio.2014.212, ISSN 1759-5002, pages 64 - 64, XP093212561
OPPOSITION- Ryszard Kole, Adrian R. Krainer, Sidney Altman, "RNA therapeutics: beyond RNA interference and antisense oligonucleotides", Nature Reviews Drug Discovery, (20120201), vol. 11, no. 2, doi:10.1038/nrd3625, ISSN 1474-1776, pages 125 - 140, XP055138361
OPPOSITION- Esther M. M. Ooi; P. Hugh R. Barrett; Dick C. Chan; Gerald F. Watts, "Apolipoprotein C-III: understanding an emerging cardiovascular risk factor", Clinical Science, GB , (20080101), vol. 114, no. 10, doi:10.1042/CS20070308, ISSN 0143-5221, pages 611 - 624, XP009556103
OPPOSITION- Daniel Gaudet, Diane Brisson, Karine Tremblay, Veronica J. Alexander, Walter Singleton, Steven G. Hughes, Richard S. Geary, Brenda F. Baker, Mark J. Graham, Rosanne M. Crooke, Joseph L. Witztum, "Targeting APOC3 in the Familial Chylomicronemia Syndrome", The New England journal of medicine, Massachusetts Medical Society, US, US , (20141204), vol. 371, no. 23, doi:10.1056/NEJMoa1400284, ISSN 0028-4793, pages 2200 - 2206, XP055301912
OPPOSITION- Mann Christopher J., Troussard Armelle A., Yen Frances T., Hannouche Nabil, Najib Jamila, Fruchart Jean-Charles, Lotteau Vincent, André Patrice, Bihain Bernard E., "Inhibitory Effects of Specific Apolipoprotein C-III Isoforms on the Binding of Triglyceride-rich Lipoproteins to the Lipolysis-stimulated Receptor", Journal of Biological Chemistry, US , (19971201), vol. 272, no. 50, doi:10.1074/jbc.272.50.31348, ISSN 0021-9258, pages 31348 - 31354, XP093190600
OPPOSITION- V. Clavey, S. Lestavel-Delattre, C. Copin, J. M. Bard, J. C. Fruchart, "Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E", Arteriosclerosis, Thrombosis, and Vascular Biology, Lippincott, Williams & Wilkins, (19950701), vol. 15, no. 7, doi:10.1161/01.ATV.15.7.963, ISSN 1079-5642, pages 963 - 971, XP009557543
OPPOSITION- Jong Miek C, Hofker Marten H, Havekes Louis M, "Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3", Arteriosclerosis, Thrombosis, and Vascular Biology, (19990301), vol. 19, no. 3, doi:10.1161/01.ATV.19.3.472, ISSN 1079-5642, pages 472 - 484, XP093190597
OPPOSITION- Miller Michael, Stone Neil J., Ballantyne Christie, Bittner Vera, Criqui Michael H., Ginsberg Henry N., Goldberg Anne Carol, Howard William James, Jacobson Marc S., Kris-Etherton Penny M., Lennie Terry A., Levi Moshe, Mazzone Theodore, Pennathur Subramanian, "Triglycerides and Cardiovascular Disease : A Scientific Statement From the American Heart Association", Circulation, US , (20110524), vol. 123, no. 20, doi:10.1161/CIR.0b013e3182160726, ISSN 0009-7322, pages 2292 - 2333, XP093190610
OPPOSITION- Zheng Chunyu, Khoo Christina, Furtado Jeremy, Sacks Frank M., "Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype", Circulation, US , (20100420), vol. 121, no. 15, doi:10.1161/CIRCULATIONAHA.109.875807, ISSN 0009-7322, pages 1722 - 1734, XP093190608
OPPOSITION- Krauss Ronald M., Levy Robert I., Fredrickson Donald S., "Selective Measurement of Two Lipase Activities in Postheparin Plasma from Normal Subjects and Patients with Hyperlipoproteinemia", Journal of Clinical Investigation, (19741101), vol. 54, no. 5, doi:10.1172/JCI107855, ISSN 0021-9738, pages 1107 - 1124, XP093190555
OPPOSITION- Aalto-Setfld Katriina, Fisher Edward A, Chen Xiaoli, Chajek-Shaul Tova, Hayek Tony, Zechner Rudolf, Walsh Annemarie, Ramakrishnan Rajasekhar, Ginsberg Henry N, Breslow Jan L, "Mechanism of Hypertriglyceridemia in Human Apolipoprotein (Apo) CIII Transgenic Mice ", The Journal of Clinical Investigation, (19921101), vol. 90, doi:10.1172/JCI116066., pages 1899 - 1900, XP093190592
OPPOSITION- Esan Oluwayemisi, Wierzbicki Anthony S, "Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy", Drug Design, Development and Therapy, United Kingdom , (20200706), vol. 14, doi:10.2147/DDDT.S224771, ISSN 1177-8881, pages 2623 - 2636, XP093190614
OPPOSITION- Krauss Ronald M., "Lipids and Lipoproteins in Patients With Type 2 Diabetes", Diabetes care, US , (20040601), vol. 27, no. 6, doi:10.2337/diacare.27.6.1496, ISSN 0149-5992, pages 1496 - 1504, XP093190602
OPPOSITION- A Borghei, Azizi, "Familial Chylomicronemia Syndrome Presenting With Acute Necrotizing Pancreatitis in a Five Month Infant", J. Nepal Paediatr. Soc, (20100101), vol. 30, no. 2, doi:10.3126/jnps.v30i2.2431, pages 110 - 112, XP055275033
SEARCH- GIUSEPPE DANILO NORATA ET AL, "Apolipoprotein C-III: From Pathophysiology to Pharmacology", TRENDS IN PHARMACOLOGICAL SCIENCES., GB, (20151001), vol. 36, no. 10, doi:10.1016/j.tips.2015.07.001, ISSN 0165-6147, pages 675 - 687, XP055301744 [T] * the whole document *
SEARCH- DANIEL GAUDET ET AL, "Targeting APOC3 in the Familial Chylomicronemia Syndrome", NEW ENGLAND JOURNAL OF MEDICINE, THE - NEJM -, (20141204), vol. 371, no. 23, doi:10.1056/NEJMoa1400284, ISSN 0028-4793, pages 2200 - 2206, XP055301912

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents